nivolumab,Ipilimumab
BMS
['nivo', 'check,mate,914', 'nivolumab', 'clear,trial', 'prosper,trial', 'checkmate 914']
#esmo22 prosper : nivolumab in perioperative setting (1 cure neoadj and 9 cures adjuvant) - no benefit in dfs. patients staged on radiological criteria (not parhological on nephrectomy specimen) with 20% non clear cell carcinoma. second negative trial ! waiting for checkmate 914 
urologue à L'institut Paoli-Calmettes à Marseille